Tharimmune appoints Vincent LoPriore to Board of Directors
15 Apr 2025 //
ACCESSWIRE
Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF
07 Apr 2025 //
ACCESSWIRE
Tharimmune gets FDA nod for TH104 to prevent opioid depression
31 Mar 2025 //
#N/A
Tharimmune Reports Positive Results for Oral Antibody TH023 Target
24 Mar 2025 //
ACCESSWIRE
Tharimmune reports success with novel biologics using EpiClick
04 Mar 2025 //
ACCESSWIRE